According to the document, a tender has been announced for the supply of tacrolimus—a drug used both in transplantation and in the treatment of autoimmune diseases. The procurement will be carried out in the format of a standard unrestricted tender. This medication is necessary to ensure the stable health condition of patients after organ transplants.
The expected expenses for the purchase amount to 123 million 193 thousand 420 soms. The acceptance of proposals will last until December 12, 2025. Participants can indicate prices in both soms and foreign currency.
Tacrolimus is an immunosuppressive agent that regulates the body's immune response after organ transplants, such as the liver, kidneys, or heart, to prevent the rejection of the transplanted organ.
